首页> 外文会议>ASME International Design Engineering Technical Conferences >DESIGN AND MODELING OF A PROSTHETIC VENOUS VALVE
【24h】

DESIGN AND MODELING OF A PROSTHETIC VENOUS VALVE

机译:假体静脉阀的设计与建模

获取原文

摘要

Chronic Venous Insufficiency (CVI) is a disease of the lower limbs that affects millions of people in the United States. CVI results from incompetent venous valves. The purpose of venous valves is to prevent retrograde blood flow to the lower limbs. Valve failure can lead to edema, pain, and ulcers. One solution that has great potential is to create an implantable venous valve that could restore function of the venous system. No prosthetic venous valves are clinically used currently because of problems with biocompatiblility and thrombogenicity caused by high shear rates. This paper presents a prosthetic venous valve that could overcome these difficulties by using carbon-infiltrated carbon nanotubes (CI-CNTs). This material has been proven to be thrombo-resistant, biocompatible due to its non-reactive properties, and durable. The valve was designed to be initially open and to close with physiological pressures. Finite element modeling showed that, with a hydrostatic pressure of 20 mmHg (the minimum hydrostatic pressure in the common femoral vein), it fully closed with a maximum stress of 117 MPa, which is below the ultimate strength of CI-CNTs. A computational fluid dynamics analysis demonstrated the valve would cause a maximum shear rate of 225.1 s~(-1), which is less than the maximum shear rate in the body. Hence, this valve would be less likely than previous prosthetic valves to develop blood clots. Currently, this is the lowest shear rate reported for a prosthetic venous valve. These results demonstrate that a CI-CNT prosthetic venous valve has the potential to be an effective treatment for CVI.
机译:慢性静脉功能不全(CVI)是下肢,影响数以百万计的人在美国的疾病。 CVI结果从无能的静脉瓣膜。静脉瓣膜的目的是为了防止逆行血流到下肢。阀的故障可导致水肿,疼痛和溃疡。有很大的潜力的一个解决方案是创建一个能够恢复静脉系统的功能的植入静脉瓣膜。没有修复静脉瓣膜在临床上目前使用的,因为与biocompatiblility引起的高剪切速率血栓形成的问题。本文提出了可以克服使用碳渗入的碳纳米管(CI-CNT)的这些困难人工静脉瓣。这种材料已被证明是血栓性,生物相容的,由于其非反应性的性质,并且耐用。该阀被设计成最初打开和关闭与生理的压力。有限元建模表明,与20毫米汞柱(在共用股静脉的最小流体静压力)的流体静压力,它完全117 MPa的最大应力,其为下面CI-CNT的极限强度关闭。表现出的阀A计算流体动力学分析将导致225.1 S〜(-1),这是小于在体内的最大剪切速率的最大剪切速率。因此,这种阀门会比以前的人工心脏瓣膜不太可能发展血块。目前,这是报告的一个人工静脉瓣的最低剪切速率。这些结果表明,一个CI-CNT假体静脉瓣必须是一种有效的治疗CVI的潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号